MINIMS FLUORESCEIN SODIUM

Երկիր: Իռլանդիա

Լեզու: անգլերեն

Աղբյուրը: HPRA (Health Products Regulatory Authority)

Ակտիվ բաղադրիչ:

FLUORESCEIN SODIUM

Հասանելի է:

Bausch & Lomb UK Limited

ATC կոդը:

S01JA01

INN (Միջազգային անվանումը):

FLUORESCEIN SODIUM

Դոզան:

1 %w/v

Դեղագործական ձեւ:

Eye Drops Solution

Ռեկվիզորի տեսակը:

Product not subject to medical prescription

Թերապեւտիկ տարածք:

fluorescein

Լիազորման կարգավիճակը:

Not Marketed

Հաստատման ամսաթիվը:

1983-04-01

Ապրանքի հատկությունները

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Minims Fluorescein Sodium 1%, w/v Eye Drops, Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1% w/v solution of Fluorescein Sodium
_For a full list of excipients, see section 6.1_
3 PHARMACEUTICAL FORM
Eye Drops, Solution (Eye Drops)
Clear, orange-red, aqueous single-use eye drop solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As a diagnostic stain.
Fluorescein does not stain a normal cornea but conjunctival abrasions
are stained yellow or orange, corneal abrasions or
ulcers are stained a bright green and foreign bodies are surrounded by
a green ring.
Fluorescein can be used in diagnostic examinations including Goldmann
tonometry and in the fitting of hard contact
lenses.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults, Children and the Elderly
Instil dropwise into the eye.
Sufficient solution should be applied to stain the damaged areas.
Excess may be washed away with sterile saline solution.
4.3 CONTRAINDICATIONS
Use in patients with a known hypersensitivity to Fluorescein.
Not to be used with soft contact lenses.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Special care should be taken to avoid microbial contamination.
Each Minims unit should be discarded after a single use.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_5_
_/_
_1_
_2_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_2_
_1_
_5_
_4_
_6_
_3_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 INTERACTION WITH OTHER MEDICINAL